price
VN
NASDAQ · VNDA
Vanda Pharmaceuticals Inc.
Healthcare · Biotechnology
$5.13
Up+$0.02 (+0.39%)
Updated Sep 19, 2026, 7:14 AM
SID Score
3.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 390.01M
- P/E ratio
- -4.61
- Dividend yield
- 0.00%
- 52-week range
- $4.27 – $9.94
- Volume
- 1.66M
- Avg. volume
- 761.61K
Price performance
VNDA price history
1M range · 20 trading sessions · Daily adjusted prices
VNDA closed at $5.13 after 20 trading sessions, down 2.84% for the selected period.
- Last close
- $5.13
- Period change
- -2.84%
- Period low
- $4.99
- Period high
- $5.53
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | $5.085 | $5.15 | $5.035 | $5.13 | 1.66M |
| Sep 17, 2026 | $4.99 | $5.17 | $4.99 | $5.11 | 646.83K |
| Sep 16, 2026 | $5.00 | $5.03 | $4.94 | $5.00 | 441.25K |
| Sep 15, 2026 | $5.17 | $5.17 | $4.955 | $4.99 | 758.87K |
| Sep 14, 2026 | $5.12 | $5.19 | $5.0408 | $5.15 | 817.81K |
| Sep 11, 2026 | $5.10 | $5.17 | $5.05 | $5.09 | 701.23K |
| Sep 10, 2026 | $5.20 | $5.20 | $5.01 | $5.04 | 958.22K |
| Sep 9, 2026 | $5.29 | $5.3463 | $5.215 | $5.25 | 715.01K |
| Sep 8, 2026 | $5.36 | $5.445 | $5.225 | $5.33 | 620.65K |
| Sep 4, 2026 | $5.29 | $5.45 | $5.29 | $5.43 | 589.45K |
| Sep 3, 2026 | $5.55 | $5.59 | $5.295 | $5.34 | 756.16K |
| Sep 2, 2026 | $5.40 | $5.64 | $5.38 | $5.53 | 621.1K |
| Sep 1, 2026 | $5.36 | $5.435 | $5.32 | $5.42 | 584.85K |
| Aug 31, 2026 | $5.23 | $5.45 | $5.205 | $5.40 | 777.32K |
| Aug 28, 2026 | $5.40 | $5.435 | $5.22 | $5.29 | 525.32K |
| Aug 27, 2026 | $5.35 | $5.48 | $5.27 | $5.44 | 545.58K |
| Aug 26, 2026 | $5.43 | $5.43 | $5.24 | $5.35 | 928.37K |
| Aug 25, 2026 | $5.34 | $5.4999 | $5.34 | $5.44 | 876.37K |
| Aug 24, 2026 | $5.335 | $5.37 | $5.20 | $5.33 | 774.3K |
| Aug 21, 2026 | $5.42 | $5.42 | $5.265 | $5.28 | 656.79K |
Latest VNDA news
The latest Smart Investors Daily articles mentioning VNDA.
Stock researchMarket Activity · Options
Loading stock research…

